INVO Fertility Draws $3.6M from Alumni Capital Equity Line, Selling 2.1M Shares
IVF is trading near its 52-week low of $0.9 (14% above the low) on light trading volume (0.1× avg).
Summary
INVO Fertility sold 2.09 million shares to Alumni Capital for $3.59 million at an average price of $1.71 per share, the first drawdown under its $15M–$50M equity line announced in July 2026.
Key Events · Financing and Capital Events · IVF
-
First Drawdown Under Equity Line
Sold 2,094,395 shares to Alumni Capital for approximately $3,591,000 at an average price of $1.71 per share under the Purchase Agreement announced July 24, 2026.
-
Dilution Impact
The 2.09 million new shares represent roughly 44% of the 4.77 million shares outstanding as of August 21, 2026, materially diluting existing holders.
-
Pricing vs. Current Market
The $1.71 average sale price is significantly above today's $1.03 stock price, indicating the company raised capital at a more favorable price than where the stock currently trades.
-
Going-Concern Context
This drawdown follows the company's going-concern warning and prior highly dilutive financing, underscoring continued reliance on equity-linked funding for operations.
Analysis · IVF · Industrial Applications And Services
The first actual drawdown under the $15M–$50M equity line with Alumni Capital has been executed, with 2,094,395 shares sold for approximately $3.59 million at an average price of $1.71 per share. This transaction, announced July 24, 2026, comes at a price well above today's $1.03, meaning the company raised capital at a favorable price relative to where the stock now trades. The sale adds roughly 2.1 million shares to the outstanding count, which was 4,771,364 as of August 21, 2026, representing meaningful dilution for existing holders. Against the backdrop of the company's going-concern warning and highly dilutive financing history, this drawdown provides needed cash but underscores the ongoing reliance on equity-linked funding.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IVF was trading at $1.03 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.6M. The 52-week trading range was $0.90 to $84.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.